logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
06/11/2026
HKEX's revenue and other income for Q3 2026 was HK$7.867 billion, up 1% year on year; profit attributable to shareholders was HK$4.859 billion, down 1% year on year.
Latest
2 m ago
Key to the Fed's rate hike outlook! Will the US October nonfarm payrolls arriving tonight become the "savior" of US stocks?
5 m ago
JPMorgan: Cuts Microchip Technology (MCHP.O) price target from $120 to $100.
10 m ago
Canada's new budget boosts investment to reduce dependence on the U.S.
11 m ago
Han's Laser: Will implement share buybacks in accordance with laws and regulations based on market and the company's actual conditions.
14 m ago
Simcere Pharmaceutical: Marketing application for zeprutinib for the treatment of rheumatoid arthritis accepted by the National Medical Products Administration
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.